PAFSC’s Second Committee to Discuss Approval for IFN-Free Hepatitis C Treatments on June 26

The Pharmaceutical Affairs and Food Sanitation Council’s (PAFSC) Second Committee on Drugs will discuss whether to approve Bristol-Myers K.K.’s daclatasvir HCl and asunaprevir at a meeting on June 26. If approved, the two products will be used in combination for...read more